Molecular tumor board in patients with metastatic breast cancer.
Saved in:
| Title: | Molecular tumor board in patients with metastatic breast cancer. |
|---|---|
| Authors: | Boscolo Bielo L; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Guerini Rocco E; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Crimini E; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Repetto M; Early Drug Development Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Lombardi M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Zanzottera C; Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, 20141, Milan, Italy., Aurilio G; Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, 20141, Milan, Italy., Barberis M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Belli C; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy., Zhan Y; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy., Battaiotto E; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Katrini J; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Marsicano R; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Zagami P; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy., Taurelli Salimbeni B; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy., Esposito A; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy., Trapani D; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Criscitiello C; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Fusco N; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Marra A; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy., Curigliano G; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy. giuseppe.curigliano@ieo.it.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy. giuseppe.curigliano@ieo.it. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Feb; Vol. 210 (1), pp. 45-55. Date of Electronic Publication: 2024 Oct 30. |
| Publication Type: | Evaluation Study; Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7217 |
|---|---|
| DOI: | 10.1007/s10549-024-07535-z |
